“In recent years, invalidation cases involving innovative drug patents, including compound patents, have exhibited something inexplicable. On the one hand, drug researchers, who have developed a succe
IP Service Senior Management Training Course was held in Beijing, hosted by China Intellectual Property Society (CIPS), All-China Patent Agents Association (ACPAA), China Trademark Association (CTA),